- CFO Spotlights
- Profiles
- John Spencer
Profile
John Spencer
Chief Financial Officer, Oragenics, Inc.
In the seat. First published here October 28, 2026; built from records as of October 28, 2026.
John Spencer has been Chief Financial Officer of Oragenics, Inc. since July 1, 2026, according to the company's filing of July 6, 2026.1
The filing gives John Spencer's previous role as Senior Controller at ORAGENICS INC.1 John Spencer already worked at Oragenics, Inc. when appointed, so the record counts the move as an internal promotion.1
Seats
The seat in the record
| Company | Title as filed | Standing |
|---|---|---|
| Oragenics, Inc. (OGEN) Pharmaceutical Preparations | Chief Financial Officer | In the seat |
Company names link to the company's page in the record at CFO Tribune, which holds the seat history.
The record
Filing by filing, latest first
- July 1, 2026effective
Oragenics, Inc. appointed John Spencer as Chief Financial Officer, effective July 1, 2026.
Effective July 1, 2026, the Board appointed John Spencer, the Company’s Senior Controller, to serve as the Company’s Chief Financial Officer.
[1] Filing by Oragenics, Inc., filed with the SEC on July 6, 2026. Read the filing. The record at CFO Tribune.
Sources
Sources
- Current report filed with the SEC, Oragenics, Inc.. U.S. Securities and Exchange Commission, EDGAR, filed July 6, 2026. sec.gov; record.
Corrections and removal
If a line here is wrong, or John Spencer wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.